CHARLOTTE, N.C. — cbdMD Inc. has regained full compliance with the continued listing standards of the NYSE American. As a result, the “.BC” indicator has been removed from the list of noncompliant issuers effective at the open of trading, December 8.
The NYSE American formally notified the Company in a letter dated December 5, 2025, confirming cbdMD has resolved all deficiencies related to Sections 1003(a)(i) and (ii) of the NYSE American Company Guide.
The Company will remain subject to NYSE American’s continued listing monitoring procedures.
Related Articles:
Advertisement
